Edition:
United States

Aveo Pharmaceuticals Inc (AVEO.OQ)

AVEO.OQ on NASDAQ Stock Exchange Capital Market

2.16USD
17 Jul 2018
Change (% chg)

-- (--)
Prev Close
$2.16
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
421,846
52-wk High
$4.24
52-wk Low
$1.91

Chart for

About

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's platform delivers insights into cancer and related disease. The Company's product candidates include Tivozanib, Ficlatuzumab, AV-203 and AV-380. Tivozanib is a selective long half-life vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI)... (more)

Overall

Beta: 1.71
Market Cap(Mil.): $344.72
Shares Outstanding(Mil.): 118.87
Dividend: --
Yield (%): --

Financials

  AVEO.OQ Industry Sector
P/E (TTM): -- 214.90 33.15
EPS (TTM): -0.57 -- --
ROI: -388.86 -3.85 13.23
ROE: -- -5.38 15.27

BRIEF-Aveo Reports Q1 Loss Per Share $0.08

* AVEO REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

May 08 2018

SEC seeks to block ex-Aveo CFO's testimony about consulting counsel

The Securities and Exchange Commission is seeking to block the former chief financial officer of Aveo Pharmaceuticals Inc from testifying at his upcoming trial that he relied on lawyers before making statements the regulator claims were misleading.

Apr 18 2018

BRIEF-Aveo Quarterly Loss Per Share $0.08

* AVEO REPORTS FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Mar 13 2018

BRIEF-Aveo Pharmaceuticals ‍Entered Into Sales Agreement With Leerink Partners

* AVEO PHARMACEUTICALS SAYS ‍ENTERED INTO A SALES AGREEMENT WITH LEERINK PARTNERS - SEC FILING

Feb 16 2018

BRIEF-AVEO Says EUSA Pharma Granted Positive NICE Recommendation For Fotivda

* AVEO ANNOUNCES EUSA PHARMA GRANTED POSITIVE NICE RECOMMENDATION FOR FOTIVDA® (TIVOZANIB) AS FIRST LINE TREATMENT FOR ADVANCED RENAL CELL CARCINOMA

Feb 12 2018

Ex-Aveo Pharmaceuticals exec avoids max penalty in SEC fraud case

A federal magistrate judge on Friday ordered the former chief medical officer of Aveo Pharmaceuticals Inc to pay a $50,000 penalty, a third of what the U.S. Securities and Exchange Commission requested, to resolve civil fraud charges.

Feb 09 2018

Competitors

  Price Chg
DAIICHI SANKYO COMPANY, LIMITED (4568.T) ¥4,707 +130.00
Eisai Co., Ltd (4523.T) ¥10,965 +40.00
Pfizer Inc. (PFE.N) $37.65 +0.27
Novartis AG (NOVN.S) CHF80.44 +2.24
Roche Holding Ltd. (ROG.S) CHF233.85 +1.85
Roche Holding Ltd. (RO.S) CHF238.60 +1.80
Bayer AG (BAYGn.DE) €93.83 +0.42
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €72.48 +0.64
AstraZeneca plc (AZN.L) 5,606.00 +55.00

Earnings vs. Estimates